Cefotaxime Compared with Nafcillin Plus Tobramycin for Serious Bacterial Infections
Authors:
- 1 October 1984
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 101 (4) , 469-477
Abstract
In a prospective, randomized, double-blind study, we compared cefotaxime with nafcillin plus tobramycin in the treatment of serious bacterial infections. Of 195 patients with suspected or proven infections who were not neutropenic, definite bacterial infections were identified in 81; 34 of 38 patients given cefotaxime and 26 of 43 given nafcillin plus tobramycin (p less than 0.01) responded to treatment. The difference in response rates occurred primarily in patients with rapidly fatal underlying disease or with an infection outside the urinary tract. A logistic regression analysis showed that treatment with cefotaxime was still associated with a higher response rate after adjusting for several potential confounding factors. Among patients treated for 3 days or more, our criteria for nephrotoxicity were met in 2 of 68 (2.9%) given cefotaxime and 16 of 57 (28.1%) given nafcillin plus tobramycin (p less than 0.001). Prolongation of the prothrombin time and enterococcal colonization did not occur more frequently with cefotaxime. We conclude that cefotaxime may be more effective and less toxic than nafcillin plus tobramycin for patients with serious bacterial infections.Keywords
This publication has 28 references indexed in Scilit:
- Risk Factors for Nephrotoxicity in Patients Treated with AminoglycosidesAnnals of Internal Medicine, 1984
- N-METHYL-THIO-TETRAZOLE INHIBITION OF THE GAMMA CARBOXYLATION OF GLUTAMIC ACID: POSSIBLE MECHANISM FOR ANTIBIOTIC-ASSOCIATED HYPOPROTHROMBINAEMIAThe Lancet, 1983
- Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infectionsThe American Journal of Medicine, 1983
- Antimicrobial Therapy for Two Serious Bacterial InfectionsArchives of internal medicine (1960), 1982
- Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of ActivityClinical Infectious Diseases, 1982
- Levels of Cefotaxime in Body Fluids and Tissues: A ReviewClinical Infectious Diseases, 1982
- Enterococcal Superinfection and Colonization After Therapy with Moxalactam, a New Broad-Spectrum AntibioticAnnals of Internal Medicine, 1981
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980
- Gentamicin Therapy in Renal Failure: A Nomogram for DosageAnnals of Internal Medicine, 1972
- A Rapid Chemical Assay for GentamicinNew England Journal of Medicine, 1972